Molina Healthcare, Inc.

Hospital & Medical Service Plans

MOHStrained7 of 10 basics passed

$197.20

+0.74%

Market cap $10.3B

$197.20

+0.74%

Market cap $10.3B

Molina Healthcare Inc provides medical insurance plans through Medicaid, the individual exchanges, and Medicare. The company operates in four reportable segments consisting of: 1) Medicaid; 2) Medicare; 3) Marketplace; and 4) Other.

It is a $10.3B financial services company. Revenue grew 2.6% over the last year, and it currently loses money.

Website: molinahealthcare.com
Location: Long Beach, CA
Employees: 19 000
Sector: Financial Services
Founded: 1980

Share price · 3 years

$340.11 → $197.20-42.0%

price only — dividends excluded

Key facts · TTM

Revenue: total sales; $44.5B
Loss: spends more than it earns; -$7.00M
Free cash flow: cash left after running the business; $269M
Net cash: more cash than debt; $4.49B
P/E: years of profit in the price; 21.8
Shares: down 6% since 2016 — buybacks; 52.9M
Volatility: beta vs the market — under 1 swings less; 0.74

Revenue, last 10 years

52-week range

Low $122.65$197.20High $242.88

Today's price is 62% of the way from the year's low to its high.

Valuation vs own history

P/E

63.3×

P/S

0.2×

80%

EV/EBITDA

31.2×

P/B

2.5×

82%

FCF yield

2.6%

23%

Share of the last ~5 years that was pricier than today (pricier than usual). Based on the daily valuation record.

Standing in Financial Services

Size$10.3Btop 84%
Revenue growth+12%top 35%
Net margin-0%top 90%
Return on equity-0%top 90%
P/E21.8×top 72%

Ranked against 129 Financial Services companies with a full CV — for P/E, lower ranks higher.

Skills

Six independent scores, 0–100, built from reported numbers and valuation history. Click a row to see how it was scored.

Valuation, Growth, Profitability, Quality and Moat lag behind.

Valuation42

P/E vs own history100th pct · 0/25
FCF yield2.6% · 5/25
P/S0.2x · 25/25
EV/EBITDA24.9x · 12/25

Growth20

Revenue CAGR13.1% · 20/25
Net income CAGR-8.0% · 0/25
EPS CAGR ~5Y-4.5% · 0/25
Fwd implied growth-42.0% · 0/25

Profitability5

ROICn/a · 0/25
ROE-0.2% · 0/25
Net margin-0.0% · 0/25
Operating margin0.5% · 5/25

Health53

Altman Zn/a · 0/25
Current ratio1.68 · 18/25
Interest coverage4.1x · 10/25
Net cash / debtNet cash · 25/25

Quality47

Piotroski F4/9 · 10/25
Beneish M-2.16 · 12/25
FCF conversion-3871% · 0/25
Margin stabilityσ 2.4% · 25/25

Moat23

ROIC >12% yearsn/a · 0/25
Median gross margin14.8% · 0/25
FCF-positive years8/10 yrs · 18/25
Worst-year net marginworst -2.6% · 5/25

How the scores work →

Experience

The company's career so far — founding, the IPO, landmark products and acquisitions, plus revenue milestones and insider buying.

FY2024Financial
Best year on record
$1.18B net income
FY2016Financial
First recorded profitable year
$52.0M net income
FY2016Financial
Revenue already above $10B
$17.8B in first reported year
1980Founded
Molina Healthcare was founded in 1980 by C

Achievements

Verifiable track record, straight from the reported numbers.

$10 000 invested in 2021 would be worth ~$6 976 today — price return only

$45.4B revenue in FY2025

Profitable 8 years in a row

19 000 employees

Strengths & watch-outs

What a bull and a bear would each point to. Both lists come from the reported numbers, not opinions.

Strengths

Net cash position after subtracting debt from cash

Watch-outs

Not profitable — 0.0% net margin
Loss-making in 1 of the recent years

Qualifications

The basics a company should meet before you research it further. Each check uses the reported numbers.

7 of 10 checks passed

Revenue growing — the company sells more than a year ago+2.6% YoY
Profitable — makes more than it spends-$7.00M TTM
Profit growing — earnings are higher than last year-12.7% YoY
Generates cash — cash left after running and investing$269M TTM
Debt under control — could handle its obligationsmore cash than debt
Established company — not a micro-cap — lower blow-up risk$10.3B market cap
Not printing shares — share count not ballooning — you keep your slice-11.7% shares over ~5y
Proven track record — years of profitability behind it9/10 profitable years
Financially stable — balance sheet not near distresshealth score 28/100
Pays a dividend — returns cash to shareholdersno data
Valuation not extreme — price not wildly above earningsP/E 21.8

Peer comparisonMolina Healthcare, Inc. vs 6 largest financial services peers — cap, P/E, growth and margin side by sideOpen ▾

Company	Market cap	P/E	Revenue growth	Net margin	Profile
MOH this company	$10.3B	21.8	+2.6%	-0.0%	Strained
BRK.A Berkshire Hathaway Inc.	$1.1T	11.6	+3.9%	22.3%	Mixed
BRK.B Berkshire Hathaway	$1.1T	11.6	+0.0%	18.0%	Strong
JPM JPMorgan Chase & Co.	$886.2B	13.6	+13.5%	32.6%	Strained
V VISA Inc.	$723.9B	31.9	+14.4%	50.8%	Solid
MA Mastercard Incorporated	$516.4B	31.7	+16.0%	46.3%	Mixed
BAC Bank of America Corporation	$380.4B	11.3	+15.9%	27.8%	Mixed

Head-to-head: MOH vs BRK.A · MOH vs BRK.B · MOH vs JPM

References

What covering analysts publish about the company — information only, not a recommendation.

Strong buy 3Buy 4Hold 17Sell 1

Appendix · Financial records

The full statements behind this CV, FY2016–FY2025. For readers who want to check the numbers.

Profit & lossRevenue $44.5B · net income -$7.00M (TTM)Open ▾

Profit & loss

Revenue and profit over the company's career — the income statement, visualised.

How FY2025 revenue flows to profit

RevenueNet income

Revenue (TTM)

$44.5B

YoY 2.6%

Net income (TTM)

-$7.00M

Margin -0.0%

Gross margin

12.7%

Operating margin

0.5%

P/E ratio

21.8

Income statement — full detail

Figures in USD billions · EPS in USD

	2020	2021	2022	2023	2024	2025
Revenue	19.4	27.8	32.0	34.1	40.6	45.4
Gross profit	1.1	4.1	4.8	5.4	6.2	5.9
Operating income (EBIT)	1.1	1.0	1.2	1.6	1.7	0.8
Net income	0.7	0.7	0.8	1.1	1.2	0.5
EPS (diluted)	11.24	11.25	13.54	18.78	20.43	8.92

Cash flowFree cash flow $269M · operating cash flow $365M (TTM)Open ▾

Cash flow statement

Cash generated by the business and what is left after investment — year by year.

Operating cash flowFree cash flow

Free cash flow (TTM)

$269M

Margin 0.6%

Operating cash flow (TTM)

$365M

FCF margin

0.6%

Cash flow statement — full detail

Figures in USD billions

	2020	2021	2022	2023	2024	2025
Operating cash flow	1.9	2.1	0.8	1.7	0.6	-0.5
Capital expenditure	-0.1	-0.1	-0.1	-0.1	-0.1	-0.1
Free cash flow	1.8	2.0	0.7	1.6	0.5	-0.6
FCF margin	9.3%	7.4%	2.1%	4.6%	1.3%	-1.4%

Balance sheetAssets $15.6B · net cash $4.49B (FY2025)Open ▾

Balance sheet

How the balance sheet is built — what it owns versus how it is financed.

How $15.6B of assets is financed

74%

26%

Liabilities $11.5B — borrowed moneyEquity $4.07B — owners' stake

Cash vs debt

Total debt $3.77B − cash $8.26B = net cash $4.49B

Cash on hand covers all debt.

Debt repayment

Not needed

Cash already covers all debt

Interest coverage

4.1x

EBIT ÷ interest expense

ROE

-0.2%

Profit per $1 of equity

Balance sheet — full detail

Figures in USD billions

	2020	2021	2022	2023	2024	2025
Cash & equivalents	6.0	7.6	7.5	9.1	9.0	8.3
Total assets	9.5	12.2	12.3	14.9	15.6	15.6
Total liabilities	7.4	9.6	9.3	10.7	11.1	11.5
Total debt	2.1	2.2	2.2	2.2	2.9	3.8
Equity	2.1	2.6	3.0	4.2	4.5	4.1
Net debt	-3.9	-5.5	-5.3	-6.9	-6.1	-4.5

Want the live picture — intraday moves, valuation history and full analysis?

Deeper analysis of MOH on PreMarketPrice

Figures are derived from company filings (quarterly values normalised from as-filed year-to-date data where applicable) and may be delayed, restated or incomplete. This page is information, not investment advice. Latest price $197.20 · market cap $10.3B.